| Names | |
|---|---|
| IUPAC name (5α,6α)-2-[(5α,6α)-3,6-dihydroxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-2-yl]-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol | |
| Identifiers | |
3D model (JSmol) | |
| Abbreviations | 2,2'-bimorphine [1] |
| ChemSpider | |
| ECHA InfoCard | 100.169.464 |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C34H36N2O6 | |
| Molar mass | 568.670 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Pseudomorphine (also known as oxydimorphine or dehydromorphine) is an inactive, natural dimerisation product of the morphine molecule in tandem and thus a common impurity in morphine concentrations. It was first described by Pelletier in 1835. [2]
This compound may be synthesized by the oxidative coupling of morphine by potassium ferricyanide. [1]
Pseudomorphine contributes very little to morphine's effects. It produces no effects in the central nervous or gastrointestinal systems, but it might have some effects on the circulatory system. [3]